Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy.

PubWeight™: 2.42‹?› | Rank: Top 2%

🔗 View Article (PMC 1682262)

Published in Am J Hum Genet on June 01, 1993

Authors

H G Harley1, S A Rundle, J C MacMillan, J Myring, J D Brook, S Crow, W Reardon, I Fenton, D J Shaw, P S Harper

Author Affiliations

1: Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.

Articles citing this

Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet (1994) 1.71

Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet (1995) 1.67

Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J Med Genet (1994) 1.54

Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet (1997) 1.53

Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46

Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet (1993) 1.28

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet (2012) 1.17

Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry (1998) 1.02

Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart (2001) 1.00

De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet (1995) 1.00

Ascertainment of myotonic dystrophy through cataract by selective screening. J Med Genet (1995) 0.97

RNA splicing is responsive to MBNL1 dose. PLoS One (2012) 0.96

Myotonic dystrophy: molecular windows on a complex etiology. Nucleic Acids Res (1998) 0.95

Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2012) 0.94

The fragile X premutation in carriers and its effect on mutation size in offspring. Am J Hum Genet (1995) 0.93

Ophthalmic manifestations of inherited neurodegenerative disorders. Nat Rev Neurol (2014) 0.92

Mild myotonic dystrophy is associated with memory impairment in the context of normal general intelligence. J Med Genet (1997) 0.91

Intelligence quotient profile in myotonic dystrophy, intergenerational deficit, and correlation with CTG amplification. J Med Genet (1994) 0.91

Clinical features of familial moyamoya disease. Childs Nerv Syst (2005) 0.90

Molecular genetics and genetic testing in myotonic dystrophy type 1. Biomed Res Int (2013) 0.88

Genetic anticipation and musculoskeletal disease. Ann Rheum Dis (1994) 0.88

The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry (2015) 0.88

Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions. J Neurol (2012) 0.87

Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy. Front Mol Neurosci (2014) 0.87

Scaled-down genetic analysis of myotonic dystrophy type 1 and type 2. Neuromuscul Disord (2009) 0.85

Towards an integrative approach to the management of myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry (2007) 0.85

Mutagenic stress modulates the dynamics of CTG repeat instability associated with myotonic dystrophy type 1. Nucleic Acids Res (2003) 0.85

Myotonic dystrophy: genetic, clinical, and molecular analysis of patients from 41 Brazilian families. J Med Genet (1995) 0.85

Additive influence of maternal and offspring DM-kinase gene CTG repeat lengths in the genesis of congenital myotonic dystrophy. Am J Hum Genet (1994) 0.84

Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments. Biomed Res Int (2013) 0.83

Cardiac involvement in myotonic dystrophy. J Community Hosp Intern Med Perspect (2015) 0.83

Influence of the sex of the transmitting grandparent in congenital myotonic dystrophy. J Med Genet (1995) 0.82

Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. PLoS One (2015) 0.82

Familial autosomal dominant dopa responsive Parkinson's disease in three living generations showing extreme anticipation and childhood onset. J Med Genet (1996) 0.82

MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1. J Neurol (2012) 0.81

Paternal transmission of congenital myotonic dystrophy. J Med Genet (1997) 0.81

Anticipation resulting in elimination of the myotonic dystrophy gene: a follow up study of one extended family. J Med Genet (1994) 0.81

Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy. Genes Dev (2017) 0.81

Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy. Eur Child Adolesc Psychiatry (2009) 0.80

Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1. J Clin Neurol (2013) 0.80

Double-strand breaks in the myotonic dystrophy type 1 and the fragile X syndrome triplet repeat sequences induce different types of mutations in DNA flanking sequences in Escherichia coli. Nucleic Acids Res (2006) 0.80

Contribution of molecular analyses to the estimation of the risk of congenital myotonic dystrophy. J Med Genet (1995) 0.80

Chronic pain in neuromuscular disease: pain site and intensity differentially impacts function. Phys Med Rehabil Clin N Am (2012) 0.80

Evidence for genetic anticipation in nodal osteoarthritis. Ann Rheum Dis (1998) 0.80

Tailoring of membrane proteins by alternative splicing of pre-mRNA. Biochemistry (2012) 0.80

Instability of normal (CTG)n alleles in the DM kinase gene. J Med Genet (1997) 0.79

RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases. Mol Med (2009) 0.79

Prevalence and correlates of apathy in myotonic dystrophy type 1. BMC Neurol (2015) 0.79

Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease. J R Soc Interface (2013) 0.79

Parental age effects, but no evidence for an intrauterine effect in the transmission of myotonic dystrophy type 1. Eur J Hum Genet (2014) 0.79

Clinical genetics in neurological disease. J Neurol Neurosurg Psychiatry (1994) 0.79

Mitochondrial DNA does not appear to influence the congenital onset type of myotonic dystrophy. J Med Genet (1995) 0.79

Frequency of myotonic dystrophy gene carriers in cataract patients. J Med Genet (1996) 0.78

Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2). J Mol Diagn (2010) 0.78

Oral motor movements and swallowing in patients with myotonic dystrophy type 1. Dysphagia (2013) 0.78

Paternal transmission of congenital myotonic dystrophy. J Med Genet (1994) 0.78

Increased severity over generations of Charcot-Marie-Tooth disease type 1A. J Neurol (2008) 0.78

Male hypogonadism in myotonic dystrophy is related to (CTG)n triplet mutation. J Endocrinol Invest (1994) 0.77

Waiting in anticipation: the genetics of pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 0.76

CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy. Am J Hum Genet (2017) 0.75

Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA). J Neurol (2017) 0.75

Bilateral Adduction Palsy in a Patient with Myotonic Dystrophy Type 1. Exp Neurobiol (2016) 0.75

Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells. Genes (Basel) (2016) 0.75

Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling. Case Rep Med (2014) 0.75

Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles. Eur J Hum Genet (2016) 0.75

Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism. Neuropsychiatr Dis Treat (2016) 0.75

Myotonic dystrophy: molecular and cellular consequences of expanded DNA repeats are elusive. J Inherit Metab Dis (1997) 0.75

Articles cited by this

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 12.74

Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science (1992) 9.32

Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature (1992) 8.85

An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (1992) 8.20

Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science (1991) 7.16

Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature (1992) 4.45

Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44

Fragile X genotype characterized by an unstable region of DNA. Science (1991) 4.33

Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet (1992) 3.39

Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet (1992) 2.85

Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet (1991) 2.65

Anticipation in myotonic dystrophy: fact or fiction? Brain (1989) 2.41

Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38

Unstable DNA sequence in myotonic dystrophy. Lancet (1992) 2.36

Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker. Am J Hum Genet (1991) 1.64

Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology (1990) 1.39

Expansion of unstable DNA region in Japanese myotonic dystrophy patients. Lancet (1992) 1.29

Myotonic dystrophy. Predictive value of normal results on clinical examination. Brain (1991) 1.24

Minimal expression of myotonic dystrophy: a clinical and molecular analysis. J Med Genet (1992) 1.05

Five years experience of predictive testing for myotonic dystrophy using linked DNA markers. Am J Med Genet (1992) 1.02

Articles by these authors

Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature (1982) 11.57

Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape. Science (2001) 8.93

Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res (1983) 8.92

Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature (1992) 8.85

Report of the Committee on the Genetic Constitution of Chromosomes 17, 18 and 19. Cytogenet Cell Genet (1985) 6.88

Human gene mutation database-a biomedical information and research resource. Hum Mutat (2000) 6.87

Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J (1991) 6.13

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70

Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet (1997) 4.92

Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain (1988) 4.69

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42

Exon amplification: a strategy to isolate mammalian genes based on RNA splicing. Proc Natl Acad Sci U S A (1991) 3.43

Homology between CAP and Fnr, a regulator of anaerobic respiration in Escherichia coli. J Mol Biol (1983) 3.08

Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child (1987) 2.95

Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88

A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet (1994) 2.85

Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet (1992) 2.85

Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82

The prevention of Huntington's chorea. The Milroy lecture 1985. J R Coll Physicians Lond (1986) 2.74

Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet (1991) 2.65

The cutest little baby face: a hormonal link to sensitivity to cuteness in infant faces. Psychol Sci (2009) 2.60

PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet (1998) 2.52

Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet (1995) 2.49

The construction and analysis of epidemic trees with reference to the 2001 UK foot-and-mouth outbreak. Proc Biol Sci (2003) 2.49

A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis. Nat Genet (1998) 2.48

The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc Natl Acad Sci U S A (1991) 2.47

The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy. J Med Genet (1983) 2.45

Early-onset dystrophia myotonica. Evidence supporting a maternal environmental factor. Lancet (1972) 2.40

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 2.38

Heterogeneous shedding of Escherichia coli O157 in cattle and its implications for control. Proc Natl Acad Sci U S A (2006) 2.37

Unstable DNA sequence in myotonic dystrophy. Lancet (1992) 2.36

Huntington's Chorea in South Wales. A genetic and epidemiological study. Clin Genet (1981) 2.31

A full genome scan for late onset Alzheimer's disease. Hum Mol Genet (1999) 2.26

Studies of a DNA marker (G8) genetically linked to Huntington disease in British families. Hum Genet (1986) 2.18

Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet (1983) 2.16

Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet (1993) 2.15

Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet (1998) 2.14

Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker. Lancet (1987) 2.09

Adoption and genetic prediction for Huntington's disease. Lancet (1988) 2.09

Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08

Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet (1997) 2.06

Polycystic kidney disease re-evaluated: a population-based study. Q J Med (1991) 2.05

Linkage disequilibrium in Huntington's disease: an improved localisation for the gene. J Med Genet (1989) 2.05

Congenital myotonic dystrophy in Britain. I. Clinical aspects. Arch Dis Child (1975) 2.04

Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02

Problems in genetic prediction for Huntington's disease. Lancet (1989) 2.00

Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet (1999) 1.98

Cardiac disease in myotonic dystrophy. Cardiovasc Res (1997) 1.98

In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res (2001) 1.97

George Otto Gey. (1899-1970). The HeLa cell and a reappraisal of its origin. Obstet Gynecol (1971) 1.93

Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst (2000) 1.92

Localization of two genes for Usher syndrome type I to chromosome 11. Genomics (1992) 1.90

Prevalence of small inversions in yeast gene order evolution. Proc Natl Acad Sci U S A (2000) 1.90

A new DNA marker tightly linked to the fragile X locus (FRAXA). Science (1989) 1.88

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet (1989) 1.87

Huntington's chorea. The basis for long-term prevention. Lancet (1979) 1.87

CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet (2002) 1.86

Further mapping of markers around the centromere of human chromosome 19. Genomics (1987) 1.84

Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83

Genetic linkage confirmed between the locus for myotonic dystrophy and the ABH-secretion and Lutheran blood group loci. Am J Hum Genet (1972) 1.82

Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet (2006) 1.80

Linkage of Usher syndrome type I gene (USH1B) to the long arm of chromosome 11. Genomics (1992) 1.79

Factors influencing age at onset and duration of survival in Huntington's chorea. Ann Hum Genet (1981) 1.79

Screening for Duchenne muscular dystrophy. Arch Dis Child (1989) 1.78

Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc Natl Acad Sci U S A (1997) 1.78

Assignment of human ferritin genes to chromosomes 11 and 19q13.3----19qter. Hum Genet (1985) 1.76

Nucleotide sequence of the fnr gene and primary structure of the Enr protein of Escherichia coli. Nucleic Acids Res (1982) 1.76

Evaluation of a call programme for cervical cytology screening in women aged 50-60. BMJ (1989) 1.75

Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum Genet (1984) 1.74

Attitudes of mothers to neonatal screening for Duchenne muscular dystrophy. BMJ (1990) 1.72

Congenital myotonic dystrophy in Britain. II. Genetic basis. Arch Dis Child (1975) 1.71

Huntington disease: no evidence for locus heterogeneity. Genomics (1989) 1.70

Incidence of mycobacterial infections in cats in Great Britain: estimate from feline tissue samples submitted to diagnostic laboratories. Transbound Emerg Dis (2012) 1.68

Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea. J Med Genet (1983) 1.67

Amplification and product identification of the fnr gene of Escherichia coli. J Gen Microbiol (1982) 1.67

Mutations in SOX9, the gene responsible for Campomelic dysplasia and autosomal sex reversal. Am J Hum Genet (1995) 1.67

Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet (1999) 1.67

A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms. J Med Genet (1982) 1.66

Decline in the predicted incidence of Huntington's chorea associated with systematic genetic counselling and family support. Lancet (1981) 1.64

Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker. Am J Hum Genet (1991) 1.64